---
schema_version: "secwatch.filing_event.v1"
accession: "0001639691-22-000098"
form_type: "8-K"
ticker: "LIVN"
cik: "0001639691"
company_name: "LivaNova PLC"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T14:15:03.397975+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# LivaNova Reports Third-Quarter 2022 Results with Revenue of $252.6M

## Summary
- Revenue of $252.6M decreased 0.2% reported but increased 5.2% on constant-currency basis vs prior year.
- GAAP diluted loss per share of $2.01 includes non-cash goodwill impairment of ~$2.40 per share; adjusted diluted EPS was $0.58.
- Michael Hutchinson named Senior Vice President, Chief Legal Officer and Company Secretary, succeeding Keyna Skeffington.
- Full-year 2022 outlook unchanged; focus on core growth drivers, clinical pipeline, and cash generation.

## SEC filing metadata
- accession: 0001639691-22-000098
- form_type: 8-K
- ticker: LIVN
- cik: 0001639691
- company_name: LivaNova PLC
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/0001639691-22-000098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/livn-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001639691-22-000098
- JSON: https://secwatch.observer/filing/0001639691-22-000098.json
- Plain text: https://secwatch.observer/filing/0001639691-22-000098.txt

## Key facts
- Earnings Releases
  LivaNova PLC reported the quarter ended September 30, 2022 results: revenue $252.6 million, EPS $2.01. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2022
  - Revenue: $252.6 million
  - EPS: $2.01
  - Guidance: reaffirmed
  - Result: reported results
  source text: Revenue of $252.6 million for the quarter decreased 0.2 percent on a reported basis and increased 5.2 percent on a constant-currency basis, as compared to the prior-year period • U.S. GAAP diluted loss per share was $2.01, including a non-cash goodwill impairment charge of approximately $2.40 per share, and adjusted diluted earnings per share was $0.58
  evidence_url: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/0001639691-22-000098-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.